The sample size was determined based on a priori power analysis using G*Power software using a moderate effect size at an alpha error probability of 0.05 [82]
Sept 11: Israelbased BioLineRx won FDA approval for Aphexda (motixafortide), a stem cell mobilization agent for patients with multiple myeloma scheduled for autologous stem cell transplantation (ASCT)
Best Candidates: Men & women with dull skin, pigmentation, melasma, uneven tone, oxidative damage, or weakened immunity Anaesthesia Used: None required (painless IV administration) Treatment Duration: 2030 minutes per infusion Hospital Stay: Not required (performed in a medical-grade clinic) Downtime: Zero downtime
While a runny nose is not the most talked-about side effect, it has become a frequent topic of conversation in patient communities and clinical discussions alike
British Columbia As with other provinces, BCs PharmaCare Plan covers the cost of Ozempic for eligible individuals with type 2 diabetes, provided they haven't been able to achieve blood sugar control with metformin
Jeremy London Board Certified Cardiovascular Surgeon, Rho Partner Rho products are built on advanced delivery technology , grounded in science, and a simple addition to my daily routine